Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Pilot Phase II Trial of the Combination of Tagraxofusp with Pacritinib in Patients with Myelofibrosis, Tagpac Study

Abdulraheem Yacoub, Tara L. Lin, Heather J Male, Kenneth P Byrd, Haitham Abdelhakim, Lisa Stewart, Maddie Jensen, Jesus D Gonzalez Lugo

Blood (2024) 144 (Supplement 1): 6641.

https://doi.org/10.1182/blood-2024-194439

Published: 2024

Journal Articles

Real-World Analysis of CPX-351 Induction in Acute Myeloid Leukemia-Myelodysplasia Related (AML-MR): An Updated Analysis from the Marrow Consortium

Daniel T Peters, Deedra Nicolet, Yazan F Madanat, Jesus D Gonzalez-Lugo, Alexander J. Ambinder, Onyee Chan, Michael Jamie Hochman, Najla H. Al Ali, Victoria Klein, Krzysztof Mrózek, Tara L. Lin, Alice Mims, Charles Foucar, Joshua F Zeidner

Blood (2024) 144 (Supplement 1): 324.

https://doi.org/10.1182/blood-2024-193667

Published: 2024

Journal Articles

Molecular Features of Acute Myeloid Leukemia in Hispanics: An Analysis from the Marrow Consortium

Blood (2024) 144 (Supplement 1): 3801.

https://doi.org/10.1182/blood-2024-212140

Published: 2024

Journal Articles

Characteristics and Outcomes of Patients with DDX41-Mutated Acute Myeloid Leukemia: A Single-Center Experience

Jayanshu Jain, Kenneth P Byrd, Heather J Male, Haitham Abdelhakim, Jesus D Gonzalez-Lugo, Tara L Lin

Blood (2023) 142 (Supplement 1): 4227.

https://doi.org/10.1182/blood-2023-181196

Published: 2023

Journal Articles

Inhibition of Toll-like Receptor 4 (TLR4) Promotes Erythroid and Myeloid Differentiation in Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Ariel Fromowitz, Srinivas Aluri, Jesus D Gonzalez Lugo, Emma Rabinovich, Nandini Ramachandra, Sarah Aminov, Srabani Sahu, Shanisha Gordon Mitchell, Ritesh Aggarwal, Opeyemi Ajibade, Milagros Carbajal, Kith Pradhan, Andrea Pellagatti, Jacqueline Boultwood, Aditi Shastri, Rongbao Zhao, Amit K. Verma

Blood (2023) 142 (Supplement 1): 5615.

https://doi.org/10.1182/blood-2023-182059

Published: 2023

Journal Articles

Real-World Outcomes with CPX-351 Induction in Adults with Newly Diagnosed Acute Myeloid Leukemia

Joseph G Bennett, Drake Gilmore, Heather J Male, Kenneth P Byrd, Tara L Lin, Jesus D Gonzalez-Lugo

Blood (2023) 142 (Supplement 1): 5924.

https://doi.org/10.1182/blood-2023-178333

Published: 2023

Journal Articles

Older Age and Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Illness Severity and COVID-Related Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms Patients: An Updated Analysis

Blood (2022) 140 (Supplement 1): 10949–10950.

https://doi.org/10.1182/blood-2022-164841

Published: 2022

Journal Articles

Seroconversion Rates after COVID-19 Vaccination Amongst Patients with Hematologic Malignancies: Results of a Rapid Vaccination and Evaluation Program in a Minority Rich, Ethnically Diverse Inner City Cohort

Blood (2021) 138 (Supplement 1): 2537.

https://doi.org/10.1182/blood-2021-151309

Published: 2021

Journal Articles

Lenalidomide and Eltrombopag for Treatment in Low or Intermediate Risk Myelodysplastic Syndrome: Result of a Phase 2 Study Combination Clinical Trial

Blood (2021) 138 (Supplement 1): 65.

https://doi.org/10.1182/blood-2021-146597

Published: 2021

Journal Articles

Older Age and Increased Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms and COVID-19 Patients

Angelica D'Aiello, Sumaira Zareef, MD, Kith Pradhan, PhD, Amanda Lombardo, PA-C, BS, MS, Fariha Khatun, PA-C, Jennat Mustafa, PA-C, Alyssa De Castro, PharmD, Felisha Joseph, PA-C, Kailyn Gillick, PA-C, Anjali Naik, PA-C, Astha Thakkar, MBBS, Lauren C Shapiro, MD, Shafia Rahman, MD, Zhu Cui, MD, Jesus D Gonzalez Lugo, MD, Fiona Mienko, MBBS, Numa Tarnima Rahman, MD, Robert Lopez, MD, Heidi Chwan Ko, DO, Amanda Podolski, MD, Vikas Mehta, MD, Sanjay Goel, MD, Rafi Kabarriti, MD, Joseph Sparano, MD, Stuart Packer, MD, David Lawrence Fernandes, MD, Enrico Castelucci, MD, Margarita Kushnir, MD, Mark Chaitowitz, MD, Luca Paoluzzi, MD, Ulrich G. Steidl, MDPhD, Phaedon Zavras, MD, Ioannis Mantzaris, MD MS, Noah Kornblum, MD, Aditi Shastri, MD, Lizamarie Bachier-Rodriguez, MD, Kira Gritsman, MDPhD, Henny H. Billett, MD MSc, Rachel Bartash, MD, Yoram Puius, MD PhD, Margaret Mccort, MD, Ira Braunschweig, MD, Mendel Goldfinger, MD, Amit Verma, MBBS, R. Alejandro Sica, MD

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-138842

Published: 2020

Journal Articles

Effect of Active Hepatitis C Infection in Relapse-Free Survival Among Patients with HIV‐Related Diffuse Large B‐Cell Lymphoma

Jesus D Gonzalez-Lugo, MD, Ana Acuna-Villaorduna, MD, Urvi A Shah, MD, Ellen W. Friedman, MD

Blood (2019) 134 (Supplement_1): 4132.

https://doi.org/10.1182/blood-2019-129379

Published: 2019

Journal Articles

Real World Treatment Patterns and Toxicity Among Elderly Patients with Multiple Myeloma

Jesus D Gonzalez-Lugo, MD, Ana Acuna-Villaorduna, MD, Joshua Heisler, MD, Niyati Goradia, MBBS, Daniel Cole, MD, Mateo Mejia Saldarriaga, MD, Aditi Shastri, MD, Gurbakhash Kaur, MD, Ira Braunschweig, MD, Noah Kornblum, MD, Amit Verma, MBBS, Murali Janakiram, MD MS, Ioannis Mantzaris, MD MS

Blood (2019) 134 (Supplement_1): 5571.

https://doi.org/10.1182/blood-2019-131114

Published: 2019

Journal Articles

Differentiating Lung Involvement in Adult T-Cell Leukemia Lymphoma (ATLL) Versus HTLV Infection: Results from a Large Single-Center Cohort with Implications for Staging and Response Criteria

Ana Acuna-Villaorduna, MD, Jesus D Gonzalez-Lugo, B. Hilda Ye, PhD, Urvi A Shah, MD, Gurbakhash Kaur, MDMA,BS, Nishi Shah, MBBS, MPH, Ioannis Mantzaris, MD MS, Aditi Shastri, MD, Ira Braunschweig, MD, Noah Kornblum, MD, Olga Derman, MD, Amit Verma, MD, Benjamin Zalta, MD, Murali Janakiram, MD MS

Blood (2018) 132 (Supplement 1): 1630.

https://doi.org/10.1182/blood-2018-99-119294

Published: 2018

Journal Articles

Higher Rates of Anticoagulation Among Patients with Portal Vein Thrombosis Are Not Associated with Better Outcomes

Ana Acuna-Villaorduna, MD, Vivy Tran, Jesus D Gonzalez-Lugo, Henny Heisler Billett, MD

Blood (2017) 130 (Supplement 1): 3702.

https://doi.org/10.1182/blood.V130.Suppl_1.3702.3702

Published: 2017

NARROW

Pilot Phase II Trial of the Combination of Tagraxofusp with Pacritinib in Patients with Myelofibrosis, Tagpac Study

Real-World Analysis of CPX-351 Induction in Acute Myeloid Leukemia-Myelodysplasia Related (AML-MR): An Updated Analysis from the Marrow Consortium

Molecular Features of Acute Myeloid Leukemia in Hispanics: An Analysis from the Marrow Consortium

Characteristics and Outcomes of Patients with DDX41-Mutated Acute Myeloid Leukemia: A Single-Center Experience

Inhibition of Toll-like Receptor 4 (TLR4) Promotes Erythroid and Myeloid Differentiation in Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Real-World Outcomes with CPX-351 Induction in Adults with Newly Diagnosed Acute Myeloid Leukemia

Older Age and Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Illness Severity and COVID-Related Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms Patients: An Updated Analysis

Seroconversion Rates after COVID-19 Vaccination Amongst Patients with Hematologic Malignancies: Results of a Rapid Vaccination and Evaluation Program in a Minority Rich, Ethnically Diverse Inner City Cohort

Lenalidomide and Eltrombopag for Treatment in Low or Intermediate Risk Myelodysplastic Syndrome: Result of a Phase 2 Study Combination Clinical Trial

Older Age and Increased Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms and COVID-19 Patients

Effect of Active Hepatitis C Infection in Relapse-Free Survival Among Patients with HIV‐Related Diffuse Large B‐Cell Lymphoma

Real World Treatment Patterns and Toxicity Among Elderly Patients with Multiple Myeloma

Differentiating Lung Involvement in Adult T-Cell Leukemia Lymphoma (ATLL) Versus HTLV Infection: Results from a Large Single-Center Cohort with Implications for Staging and Response Criteria

Higher Rates of Anticoagulation Among Patients with Portal Vein Thrombosis Are Not Associated with Better Outcomes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only